Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02396199 · ClinicalTrials.gov registry record · NA
Zenith® p-Branch® Endovascular Graft Pivotal Study
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02396199 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 80 participants.
The verdict
NCT02396199, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
Interventions
- DEVICE Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-08 |
| Est. Completion | 2025-01-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02396199
The ClinicalTrials.gov registry entry for NCT02396199 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents is the first listed.
NCT02396199 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02396199 about?
NCT02396199 is a clinical study titled "Zenith® p-Branch® Endovascular Graft Pivotal Study". The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.
What is the current status of trial NCT02396199?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-08. Estimated completion is 2025-01-28.
What interventions are being tested in trial NCT02396199?
The interventions under investigation include: Zenith® p-Branch® in combination with the Atrium iCAST™ covered stents (DEVICE).
Who is sponsoring clinical trial NCT02396199?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.